These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24206603)

  • 21. Protein-leaking membranes for hemodialysis: a new class of membranes in search of an application?
    Ward RA
    J Am Soc Nephrol; 2005 Aug; 16(8):2421-30. PubMed ID: 15975998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of high-flux hemodialysis on renal anemia.
    Ayli D; Ayli M; Azak A; Yüksel C; Kosmaz GP; Atilgan G; Dede F; Abayli E; Camlibel M
    J Nephrol; 2004; 17(5):701-6. PubMed ID: 15593038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
    Pellicano R; Polkinghorne KR; Kerr PG
    Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modalities of hemodialysis: quality improvement.
    Karkar A
    Saudi J Kidney Dis Transpl; 2012 Nov; 23(6):1145-61. PubMed ID: 23168842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized controlled pilot study of 2 weeks' treatment with high cutoff membrane for hemodialysis patients with elevated C-reactive protein.
    Fiedler R; Neugebauer F; Ulrich C; Wienke A; Gromann C; Storr M; Böhler T; Seibert E; Girndt M
    Artif Organs; 2012 Oct; 36(10):886-93. PubMed ID: 22845695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
    Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
    J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of dialysis dose and membrane flux in maintenance hemodialysis.
    Eknoyan G; Beck GJ; Cheung AK; Daugirdas JT; Greene T; Kusek JW; Allon M; Bailey J; Delmez JA; Depner TA; Dwyer JT; Levey AS; Levin NW; Milford E; Ornt DB; Rocco MV; Schulman G; Schwab SJ; Teehan BP; Toto R;
    N Engl J Med; 2002 Dec; 347(25):2010-9. PubMed ID: 12490682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?
    Mrowka C; Heintz B; Sieberth HG
    Clin Nephrol; 1999 Nov; 52(5):312-21. PubMed ID: 10584995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Achieving more frequent and longer dialysis for the majority: wearable dialysis and implantable artificial kidney devices.
    Fissell WH; Roy S; Davenport A
    Kidney Int; 2013 Aug; 84(2):256-64. PubMed ID: 23407434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preliminary Diffusive Clearance of Silicon Nanopore Membranes in a Parallel Plate Configuration for Renal Replacement Therapy.
    Kim S; Heller J; Iqbal Z; Kant R; Kim EJ; Durack J; Saeed M; Do L; Hetts S; Wilson M; Brakeman P; Fissell WH; Roy S
    ASAIO J; 2016; 62(2):169-75. PubMed ID: 26692401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Activation of monocytes during hemodialysis].
    Stetsiuk EA; Osmolovskaia SV; Koval'chuk LV; Gankovskaia LV; Iarmolinskiĭ IS
    Ter Arkh; 1988; 60(6):57-60. PubMed ID: 3206372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The wearable artificial kidney: a promise for the future?].
    Wester M; Gerritsen KG; Boer WH; Joles JA; Kooman JP
    Ned Tijdschr Geneeskd; 2013; 157(52):A6965. PubMed ID: 24382046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biocompatible dialysis membranes and acute renal failure: a study in post-operative acute tubular necrosis in cadaveric renal transplant recipients.
    Valeri A; Radhakrishnan J; Ryan R; Powell D
    Clin Nephrol; 1996 Dec; 46(6):402-9. PubMed ID: 8982557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dialyzer membrane permeability and survival in hemodialysis patients.
    Chauveau P; Nguyen H; Combe C; Chêne G; Azar R; Cano N; Canaud B; Fouque D; Laville M; Leverve X; Roth H; Aparicio M;
    Am J Kidney Dis; 2005 Mar; 45(3):565-71. PubMed ID: 15754279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of two different dialysis membranes on leukocyte adhesion and aggregation.
    Hernandez MR; Palomo M; Fuste B; Carbó C; Collado S; Cases A; Escolar G
    Nephron Clin Pract; 2007; 106(1):c1-8. PubMed ID: 17347577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodialysis biocompatibility mathematical models to predict the inflammatory biomarkers released in dialysis patients based on hemodialysis membrane characteristics and clinical practices.
    Abdelrasoul A; Westphalen H; Saadati S; Shoker A
    Sci Rep; 2021 Nov; 11(1):23080. PubMed ID: 34845257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Portable and wearable dialysis: where are we now?
    Davenport A; Ronco C; Gura V
    Hemodial Int; 2010 Oct; 14 Suppl 1():S22-6. PubMed ID: 21040415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frontiers in hemodialysis: Innovations and technological advances.
    Basile C; Davenport A; Mitra S; Pal A; Stamatialis D; Chrysochou C; Kirmizis D
    Artif Organs; 2021 Feb; 45(2):175-182. PubMed ID: 32780472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uraemic itching: do polymethylmethacrylate dialysis membranes play a role?
    Aucella F; Vigilante M; Gesuete A; Maruccio G; Specchio A; Gesualdo L
    Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v8-12. PubMed ID: 17586845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.